Institutional futility policies are inherently unfair

HEC Forum

Volumn 25, Issue 3, 2013, Pages 191-209

  Rosoff, Philip M ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Futility; Medical decision making; Procedural justice

Indexed keywords

ARTICLE; DECISION MAKING; ETHNIC GROUP; HUMAN; POLICY; TREATMENT OUTCOME; UNITED STATES;

DECISION MAKING; ETHNIC GROUPS; HUMANS; MEDICAL FUTILITY; ORGANIZATIONAL POLICY; UNITED STATES;

EID: 84885190384     PISSN: 09562737     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10730-012-9194-9     Document Type: Article

References (91)

1. Allen, L. A., Yager, J. E., Funk, M. J., Levy, W. C., Tulsky, J. A., Bowers, M. T., et al. (2008). Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. Journal of the American Medical Association, 299(21), 2533-2542. doi: 10.1001/jama.299.21.2533.
2. Alpers, A., & Lo, B. (1999). Avoiding family feuds: Responding to surrogate demands for life-sustaining interventions. The Journal of Law, Medicine & Ethics, 27(1), 74-80.
3. Anonymous. (1968). A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. Journal of the American Medical Association, 205(6), 337-340.
4. Baily, M. A. (2011). Futility, autonomy, and cost in end-of-life care. The Journal of Law, Medicine & Ethics, 39(2), 172-182. doi: 10.1111/j.1748-720X.2011.00586.x.
5. Bernat, J. L. (2005). Medical futility: Definition, determination, and disputes in critical care. Neurocritical Care, 2(2), 198-205.
6. Bernat, J. L. (2009). Brain death. In S. Laureys & G. Tononi (Eds.), The neurology of consciousness. Cognitive neuroscience and neuropathology (pp. 151-161). London: Academic Press.
7. Bissel, A. (2010). Order at the end of life: Establishing a clear and fair mechanism for the resolution of futility disputes. Vanderbilt Law Review, 63, 491-540.
8. Blackhall, L. J., Frank, G., Murphy, S. T., Michel, V., Palmer, J. M., & Azen, S. P. (1999). Ethnicity and attitudes towards life sustaining technology. Social Science and Medicine, 48(12), 1779-1789.
9. Boulware, L. E., Cooper, L. A., Ratner, L. E., LaVeist, T. A., & Powe, N. R. (2003). Race and trust in the health care system (research articles). Public Health Reports, 118(4), 358-365.
10. Brett, A. S. (2005). Futility revisited: Reflections on the perspectives of families, physicians, and institutions. HEC Forum, 17(4), 276-293. doi: 10.1007/s10730-005-5154-y.
11. Burns, J. P., & Truog, R. D. (2007). Futility. Chest, 132(6), 1987-1993. doi: 10.1378/chest.07-1441.
12. Callahan, D. (1998). False hopes. Why America's quest for perfect health is a recipe for failure. New York: Simon and Shuster.
13. Callahan, D. (2009). Taming the beloved beast, chap. 6. Princeton: Princeton University Press.
14. Cohen, J., van Delden, J., Mortier, F., Lofmark, R., Norup, M., Cartwright, C., et al. (2008). Influence of physicians' life stances on attitudes to end-of-life decisions and actual end-of-life decision-making in six countries. Journal of Medical Ethics, 34(4), 247-253.
15. Cruz-Flores, S., Rabinstein, A., Biller, J., Elkind, M. S., Griffith, P., Gorelick, P. B., et al. (2011). Racial-ethnic disparities in stroke care: The American experience: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42(7), 2091-2116. doi: 10.1161/STR.0b013e3182213e24.
16. Curlin, F. A., Lawrence, R. E., Chin, M. H., & Lantos, J. D. (2007a). Religion, conscience, and controversial clinical practices. New England Journal of Medicine, 356(6), 593-600.
17. Curlin, F. A., Sellergren, S. A., Lantos, J. D., & Chin, M. H. (2007b). Physicians' observations and interpretations of the influence of religion and spirituality on health. Archives of Internal Medicine, 167(7), 649-654.
18. Daniels, N., & Sabin, J. (2008). Setting limits fairly. Learning to share resources for health (2nd ed.). Oxford: Oxford University Press.
19. Degenholtz, H. B., Thomas, S. B., & Miller, M. J. (2003). Race and the intensive care unit: Disparities and preferences for end-of-life care. Critical Care Medicine, 31(5 Suppl), S373-S378.
20. Diekema, D. S. (1996). The preferential treatment of VIPs in the emergency department. The American Journal of Emergency Medicine, 14(2), 226-229. doi: 10.1016/S0735-6757(96)90137-0.
21. Fine, R. L. (2000). Medical futility and the Texas Advance Directives Act of 1999. Proceedings, 13(2), 144-147.
22. Fine, R. L. (2001). The Texas Advance Directives Act of 1999: Politics and reality. HEC Forum, 13(1), 59-81.
23. Fine, R. L. (2009). Point: The Texas Advance Directives Act effectively and ethically resolves disputes about medical futility. Chest, 136(4), 963-967. doi: 10.1378/chest.09-1267.
24. Fine, R. L., & Mayo, T. W. (2003). Resolution of futility by due process: Early experience with the Texas Advance Directives Act. Annals of Internal Medicine, 138(9), 743-746.
25. Fox, R. C. (1957). Training for uncertainty. In R. K. Meron, G. G. Reader, & P. L. Kendall (Eds.), The student-physician (pp. 207-244). Cambridge, MA: Harvard University Press.
26. Gabbay, E., Calvo-Broce, J., Meyer, K., Trikalinos, T., Cohen, J., & Kent, D. (2010). The empirical basis for determinations of medical futility. Journal of General Internal Medicine, 25(10), 1083-1089. doi: 10.1007/s11606-010-1445-3.
27. Galambos, C. M. (1998). Preserving end-of-life autonomy: The Patient Self-Determination Act and the Uniform Health Care Decisions Act. Health and Social Work, 23(4), 275-281.
28. Gampel, E. (2006). Does professional autonomy protect medical futility judgments? Bioethics, 20(2), 92-104.
29. Gregory, P. C., LaVeist, T. A., & Simpson, C. (2006). Racial disparities in access to cardiac rehabilitation (multicenter study). American Journal of Physical Medicine & Rehabilitation/Association of Academic Physiatrists, 85(9), 705-710. doi: 10.1097/01.phm.0000233181.34999.3d.
30. Gust, D. A., Darling, N., Kennedy, A., & Schwartz, B. (2008). Parents with doubts about vaccines: Which vaccines and reasons why. Pediatrics, 122(4), 718-725. doi: 10.1542/peds.2007-0538.
31. Guzman, J. A., Sasidhar, M., & Stoller, J. K. (2011). Caring for VIPs: Nine principles. Cleveland Clinic Journal of Medicine, 78(2), 90-94. doi: 10.3949/ccjm.78a.10113.
32. Hakim, R. B., Teno, J. M., Harrell, F. E, Jr, Knaus, W. A., Wenger, N., Phillips, R. S., et al. (1996). Factors associated with do-not-resuscitate orders: Patients' preferences, prognoses, and physicians' judgments. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatment. Annals of Internal Medicine, 125(4), 284-293.
33. Halevy, A. (2008). Medical futility, patient autonomy, and professional integrity: Finding the appropriate balance (historical article). Health Matrix, 18(2), 261-290.
34. Halevy, A., & Brody, B. A. (1996). A multi-institution collaborative policy on medical futility. Journal of the American Medical Association, 276(7), 571-574. doi: 10.1001/jama.1996.03540070067035.
35. Hanchate, A., Kronman, A. C., Young-Xu, Y., Ash, A. S., & Emanuel, E. (2009). Racial and ethnic differences in end-of-life costs: Why do minorities cost more than whites? Archives of Internal Medicine, 169(5), 493-501. doi: 10.1001/archinternmed.2008.616.
36. Heilig, S., Andereck, W., Brody, R., Burns, P., Luce, J. M., Kennedy, W. K., et al. (1999). Nonbeneficial or futile medical treatment: Conflict resolution guidelines for the San Francisco Bay area. Bay Area Network of Ethics Committees (BANEC) Nonbeneficial Treatment Working Group. Western Journal of Medicine, 170(5), 287-290.
37. Heitman, E., & Gremillion, V. (2001). Ethics committees under Texas law: Effects of the Texas Advance Directives Act (evaluation studies). HEC Forum: An Interdisciplinary Journal on Hospitals' Ethical and Legal Issues, 13(1), 82-104.
38. Helft, P. R., Siegler, M., & Lantos, J. (2000). The rise and fall of the futility movement. New England Journal of Medicine, 343(4), 293-296. doi: 10.1056/NEJM200007273430411.
39. Hurst, S. A., Reiter-Theil, S., Slowther, A. M., Pegoraro, R., Forde, R., & Danis, M. (2008). Should ethics consultants help clinicians face scarcity in their practice? Journal of Medical Ethics, 34(4), 241-246. doi: 10.1136/jme.2006.019828.
40. Jacobs, H. C. (2009). The Texas Advance Directives Act - is it a good model? Seminars in Perinatology, 33(6), 384-390. doi: 10.1053/j.semperi.2009.07. 006.
41. Jecker, N. S., & Schneiderman, L. J. (1992). Futility and rationing. American Journal of Medicine, 92(2), 189-196. doi: 10.1016/0002-9343(92)90111-n.
42. Johnson, K. S., Kuchibhatla, M., & Tulsky, J. A. (2008). What explains racial differences in the use of advance directives and attitudes toward hospice care? (research support, N.I.H., Extramural). Journal of the American Geriatrics Society, 56(10), 1953-1958. doi: 10.1111/j.1532-5415.2008. 01919.x.
43. Johnson, R. W., Newby, L. K., Granger, C. B., Cook, W. A., Peterson, E. D., Echols, M., et al. (2010). Differences in level of care at the end of life according to race. American Journal of Critical Care, 19(4), 335-343. doi: 10.4037/ajcc2010161.
44. Kagawa-Singer, M., & Blackhall, L. J. (2001). Negotiating cross-cultural issues at the end of life: "You got to go where he lives". JAMA, 286(23), 2993-3001.
45. Katz, M. (2011). When is medical care "futile"? The institutional competence of the medical profession regarding the provision of life = sustaining care. Nebraska Law Review, 90, 1-69.
46. Lantos, J. (2006). When parents request seemingly futile treatment for their children. Mount Sinai Journal of Medicine, 73(3), 587-589.
47. Lantos, J. D., Singer, P. A., Walker, R. M., Gramelspacher, G. P., Shapiro, G. R., Sanchez-Gonzalez, M. A., et al. (1989). The illusion of futility in clinical practice. American Journal of Medicine, 87(1), 81-84.
48. Larochelle, M. R., Rodriguez, K. L., Arnold, R. M., & Barnato, A. E. (2009). Hospital staff attributions of the causes of physician variation in end-of-life treatment intensity (multicenter study research support, N.I.H., Extramural). Palliative Medicine, 23(5), 460-470. doi: 10.1177/0269216309103664.
49. Melichar, L. (2009). The effect of reimbursement on medical decision making: Do physicians alter treatment in response to a managed care incentive? Journal of Health Economics, 28(4), 902-907. doi: 10.1016/j.jhealeco.2009.03. 004.
50. Montgomery, K. (2006). How doctors think. New York: Oxford University Press.
51. Moratti, S. (2009). The development of "medical futility": Towards a procedural approach based on the role of the medical profession. Journal of Medical Ethics, 35(6), 369-372. doi: 10.1136/jme.2008.027755.
52. Morrison, R. S., & Meier, D. E. (2004). High rates of advance care planning in New York City's elderly population (clinical trial randomized controlled trial research support, non-U.S. Gov't research support, U.S. Gov't, P.H.S.). Archives of Internal Medicine, 164(22), 2421-2426. doi: 10.1001/archinte.164.22.2421.
53. Moseley, K. L., Church, A., Hempel, B., Yuan, H., Goold, S. D., & Freed, G. L. (2004). End-of-life choices for African-American and white infants in a neonatal intensive-care unit: A pilot study. Journal of the National Medical Association, 96(7), 933-937.
54. Moylan, C. A., Brady, C. W., Johnson, J. L., Smith, A. D., Tuttle-Newhall, J. E., & Muir, A. J. (2008). Disparities in liver transplantation before and after introduction of the MELD score. JAMA, 300(20), 2371-2378.
55. Muni, S., Engelberg, R. A., Treece, P. D., Dotolo, D., & Curtis, J. R. (2011). The influence of race/ethnicity and socioeconomic status on end-of-life care in the ICU. Chest, 139(5), 1025-1033. doi: 10.1378/chest.10- 3011.
56. O'Callaghan, N. (2008). When Atlas shrugged: May the state wash its hands of those in need of life-sustaining medical treatment? Health Matrix, 18, 291-372.
57. Okhuysen-Cawley, R., McPherson, M. L., & Jefferson, L. S. (2007). Institutional policies on determination of medically inappropriate interventions: Use in five pediatric patients. Pediatric Critical Care Medicine, 8(3), 225-230. doi: 10.1097/01.PCC.0000264317.83788.ED.
58. Pellegrino, E. D. (2005). Futility in medical decisions: The word and the concept. HEC Forum, 17(4), 308-318. doi: 10.1007/s10730-005-5156-9.
59. Poses, R. M., Bekes, C., Copare, F. J., & Scott, W. E. (1989). The answer to "What are my chances, Doctor?" depends on whom is asked: Prognostic disagreement and inaccuracy for critically ill patients. Critical Care Medicine, 17(8), 827-833.
60. Poses, R. M., McClish, D. K., Bekes, C., Scott, W. E., & Morley, J. N. (1991). Ego bias, reverse ego bias, and physicians' prognostic. Critical Care Medicine, 19(12), 1533-1539.
61. Prendergast, T. J. (1995). Futility and the common cold. Chest, 107(3), 836-844. doi: 10.1378/chest.107.3.836.
62. President's Council on Bioethics. (2008). Controversies in the determination of death. Washington, D.C.: Department of Health and Human Services.
63. Rajakumar, K., Thomas, S. B., Musa, D., Almario, D., & Garza, M. A. (2009). Racial differences in parents' distrust of medicine and research (comparative study research support, N.I.H., Extramural). Archives of Pediatrics and Adolescent Medicine, 163(2), 108-114. doi: 10.1001/archpediatrics.2008.521.
64. Rawls, J. (1999). A theory of justice (revised ed.). Cambridge, MA: Harvard University Press.
65. Rosoff, P. M., & Coleman, D. L. (2011). The case for legal regulation of physicians' off-label prescribing. Notre Dame Law Review, 86(2), 649-691.
66. Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1990). Medical futility: Its meaning and ethical implications. Annals of Internal Medicine, 112(12), 949-954. doi: 10.1059/0003-4819-112-12-949.
67. Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1996). Medical futility: Response to critiques. Annals of Internal Medicine, 125(8), 669-674. doi: 10.1059/0003-4819-125-8-199610150-00007.
68. Shafrin, J. (2010). Operating on commission: Analyzing how physician financial incentives affect surgery rates (comparative study). Health Economics, 19(5), 562-580. doi: 10.1002/hec.1495.
69. Silveira, M. J., Kim, S. Y. H., & Langa, K. M. (2010). Advance directives and outcomes of surrogate decision making before death. New England Journal of Medicine, 362(13), 1211-1218. doi: 10.1056/NEJMsa0907901.
70. Smally, A. J., Carroll, B., Carius, M., Tilden, F., & Werdmann, M. (2011). Treatment of VIPs. Annals of Emergency Medicine, 58(4), 397-398. doi: 10.1016/j.annemergmed.2011.05.009.
71. Smith, M. L. (2008). Medical inappropriateness review: Appropriately performed by a medical committee. Health Matrix: Journal of Law-Medicine, 18(2), 237-244.
72. Smith, M. L., Gremillion, G., Slomka, J., & Warneke, C. L. (2007). Texas hospitals' experience with the Texas Advance Directives Act. Critical Care Medicine, 35(5), 1271-1276.
73. Stewart, C. (2011). Futility determination as a process: Problems with medical sovereignty, legal issues and the strengths and weakness of the procedural approach. Journal of Bioethical Inquiry, 8(2), 155-163. doi: 10.1007/s11673-011-9297-z.
74. Truog, R. D. (2000). Futility in pediatrics: From case to policy. Journal of Clinical Ethics, 11(2), 136-141.
75. Truog, R. D. (2007). Brain death - too flawed to endure, too ingrained to abandon. Journal of Law, Medicine & Ethics, 35(2), 273-281.
76. Truog, R. D. (2008). End-of-life decision-making in the United States. European Journal of Anaesthesiology, 25(Supplement S42), 43-50. doi: 10.1017/S0265021507003419.
77. Truog, R. D. (2009a). Counterpoint: The Texas Advance Directives Act is ethically flawed. Chest, 136(4), 968-971. doi: 10.1378/chest.09-1269.
78. Truog, R. D. (2009). Counterpoint: The Texas Advance Directives Act is ethically flawed: Medical futility disputes must be resolved by a fair process (comment comparative study). Chest, 136(4), 968-971; discussion 971-963. doi: 10.1378/chest.09-1269.
79. Truog, R. D., & Mitchell, C. (2006). Futility - from hospital policies to state laws. American Journal of Bioethics, 6(5), 19-21; discussion W30-12. doi: 10.1080/15265160600858989.
80. Tversky, A., & Kahneman, D. (1974). Judgment under uncertainty: Heuristics and biases. Science, 185(4157), 1124-1131.
81. Ubel, P. A. (2001). Pricing life. Why it's time for health care rationing. Cambridge, MA: MIT Press.
82. Ubel, P. A., & Goold, S. (1997). Recognizing bedside rationing: Clear cases and tough calls. Annals of Internal Medicine, 126(1), 74-80.
83. Vig, E., Starks, H., Taylor, J., Hopley, E., & Fryer-Edwards, K. (2007). Surviving surrogate decision-making: What helps and hampers the experience of making medical decisions for others. Journal of General Internal Medicine, 22(9), 1274-1279. doi: 10.1007/s11606-007-0252-y.
84. Volandes, A. E., Paasche-Orlow, M., Gillick, M. R., Cook, E. F., Shaykevich, S., Abbo, E. D., et al. (2008). Health literacy not race predicts end-of-life care preferences. Journal of Palliative Medicine, 11(5), 754-762.
85. Waters, C. M. (2001). Understanding and supporting African Americans' perspectives of end-of-life care planning and decision making. Qualitative Health Research, 11(3), 385-398.
86. White, D. B., Engelberg, R. A., Wenrich, M. D., Lo, B., & Curtis, J. R. (2010). The language of prognostication in intensive care units. Medical Decision Making, 30(1), 76-83. doi: 10.1177/0272989x08317012.
87. Wijdicks, E. F. (2001). The diagnosis of brain death. New England Journal of Medicine, 344(16), 1215-1221.
88. Wilkinson, D. (2009). The self-fulfilling prophecy in intensive care. Theoretical Medicine and Bioethics, 30(6), 401-410. doi: 10.1007/s11017-009- 9120-6.
89. Wojtasiewicz, M. E. (2006). Damage compounded: Disparities, distrust, and disparate impact in end-of-life conflict resolution policies. American Journal of Bioethics, 6(5), 8-12. doi: 10.1080/15265160600856801.
90. Zier, L. S., Burack, J. H., Micco, G., Chipman, A. K., Frank, J. A., Luce, J. M., et al. (2008). Doubt and belief in physicians' ability to prognosticate during critical illness: The perspective of surrogate decision makers. Critical Care Medicine, 36(8), 2341-2347. doi: 10.1097/CCM. 0b013e318180ddf9.
91. Zimrin, A. B., & Hess, J. R. (2007). Planning for pandemic influenza: Effect of a pandemic on the supply and demand for blood products in the United States. Transfusion, 47(6), 1071-1079.